Thalamus

Education

Free · Designed for iPad

Thalamus is developed through a collaboration of trainees, administrators, coordinators, directors and GME leadership to provide comprehensive online interview scheduling and travel coordination via a real-time scheduling system – online and mobile. Thalamus streamlines communication and interview scheduling for medical residency and fellowship applicants by facilitating self-scheduling, thereby eliminating unnecessary phone calls and emails. The software manages all confirmations, cancellations, rescheduling, and wait lists, so that applicants can instantaneously confirm interview dates and take full control of their schedules. Now featured nationally at 125+ institutions and used by >75% of applicants, Thalamus is the most comprehensive and preferred interview management solution in GME.

  • 3.8
    out of 5
    462 Ratings

Various bug fixes

The developer, SJ MedConnect, Inc., indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Linked to You

    The following data may be collected and linked to your identity:

    • Contact Info
    • Identifiers
  • Data Not Linked to You

    The following data may be collected but it is not linked to your identity:

    • Usage Data

Privacy practices may vary, for example, based on the features you use or your age. Learn More

The developer has not yet indicated which accessibility features this app supports. Learn More

  • Seller
    • SJ Medconnect, Inc.
  • Size
    • 115.5 MB
  • Category
    • Education
  • Compatibility
    Requires iOS 14.0 or later.
    • iPhone
      Requires iOS 14.0 or later.
    • iPad
      Requires iPadOS 14.0 or later.
    • iPod touch
      Requires iOS 14.0 or later.
    • Mac
      Requires macOS 11.0 or later and a Mac with Apple M1 chip or later.
    • Apple Vision
      Requires visionOS 1.0 or later.
  • Languages
    • English
  • Age Rating
    4+
  • Copyright
    • © SJ MedConnect Inc. 2024